Investing.com - Gentex (NASDAQ: GNTX) reported second quarter EPS of $0.37, $0.15 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $572.9M versus the consensus estimate of $622.98M.
Guidance
Gentex sees FY 2024 revenue of $2.40B-$2.50B versus the analyst consensus of $2.49B.
Gentex's stock price closed at $32.56. It is down -6.60% in the last 3 months and up 2.55% in the last 12 months.
Gentex saw 0 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Gentex's stock price’s past reactions to earnings here.
According to InvestingPro, Gentex's Financial Health score is "good performance".
Check out Gentex's recent earnings performance, and Gentex's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar